La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:La Jolla Institute for Allergy & Immunology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9345
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
La Jolla Institute for Allergy & Immunology (LIAI) is a biomedical research institute that offers solutions for infectious agents and cancers. The institute provides research on prevention, treatment, and cure of immune system diseases. Its activities include disease research on allergy and asthma, cancer, diabetes, infectious disease, inflammation biology, microbiology and immunology, and RNAi research. LIAI also offers autoimmune research on rheumatoid arthritis, type 1 diabetes, multiple sclerosis and Crohn’s disease, among others. The institute operates through various research centers located across the US. LIAI is headquartered in La Jolla, California, the US.

La Jolla Institute for Allergy & Immunology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
La Jolla Institute Enters Into Agreement With Kyowa Hakko Kirin California For Drug Discovery 12
Licensing Agreements 13
Turnstone Biologics Enters into Licensing Agreement with La Jolla Institute for Allergy and Immunology 13
Equity Offering 14
CHIME BioTherapeutics Spin-Off from La Jolla Institute for Allergy and Immunology 14
La Jolla Institute for Allergy & Immunology – Key Competitors 15
La Jolla Institute for Allergy & Immunology – Key Employees 16
La Jolla Institute for Allergy & Immunology – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Apr 12, 2018: LJI Researchers are One Step Closer to an Effective Anti-Atherosclerosis Vaccine 18
Product News 19
Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 19
Jun 20, 2017: San Diego team tests best delivery mode for potential HIV vaccine 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Key Facts 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
La Jolla Institute Enters Into Agreement With Kyowa Hakko Kirin California For Drug Discovery 12
Turnstone Biologics Enters into Licensing Agreement with La Jolla Institute for Allergy and Immunology 13
CHIME BioTherapeutics Spin-Off from La Jolla Institute for Allergy and Immunology 14
La Jolla Institute for Allergy & Immunology, Key Competitors 15
La Jolla Institute for Allergy & Immunology, Key Employees 16

List of Figures
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnPro Industries Inc (NPO):企業の財務・戦略的SWOT分析
    Summary EnPro Industries Inc (EnPro) is a diversified company that offers engineering solutions. The company designs, develops, manufactures and markets proprietary engineered industrial products. It provides commercial vehicle wheel-end components. EnPro offers sealing solutions for a wide range of …
  • Control4 Corp (CTRL):企業の財務・戦略的SWOT分析
    Control4 Corp (CTRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • LegoChem Biosciences Inc (141080):企業の財務・戦略的SWOT分析
    Summary LegoChem Biosciences Inc (LCB) is a bio pharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of anti …
  • Duopharma Biotech Berhad (DPHARMA):企業の財務・戦略的SWOT分析
    Summary Duopharma Biotech Berhad (Duopharma), formerly CCM Duopharma Biotech Berhad, focuses on research, development and commercialization of generic drugs and biosimilars. The company manufactures and distributes pharmaceutical products to treat oncology and diabetes; musculo-skeletal, alimentary …
  • Groupe Bruxelles Lambert SA (GBLB):企業の財務・戦略的SWOT分析
    Groupe Bruxelles Lambert SA (GBLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Tullow Oil Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Tullow Oil Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Tullow Oil Plc (Tullow) is an independent upstream oil and gas company. It explores for, develops and produces oil and natural gas in Africa and South America. The company has licenses, both onshore and o …
  • Albéa Beauty Holdings S.A.:企業の戦略・SWOT・財務情報
    Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report Summary Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hrvatski Telekom d.d. (HT-R-A):企業の財務・戦略的SWOT分析
    Hrvatski Telekom d.d. (HT-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Bm-Bank Public Joint Stock Company:企業の戦略・SWOT・財務分析
    Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report Summary Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Black & Veatch Holding Company:企業の戦略・SWOT・財務分析
    Black & Veatch Holding Company - Strategy, SWOT and Corporate Finance Report Summary Black & Veatch Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Interconexion Electrica SA ESP (ISA):企業の財務・戦略的SWOT分析
    Interconexion Electrica SA ESP (ISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Toma Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Toma Biosciences Inc (Toma Biosciences) is a provider of genome sequencing solutions. The company launched TOMA OS-Seq cancer assay to laboratories and researchers for the changes in tumors. Its products include reagent kits that are developed to detect genomic changes in cancer and TOMA OS- …
  • Inscape Corporation:企業の戦略・SWOT・財務情報
    Inscape Corporation - Strategy, SWOT and Corporate Finance Report Summary Inscape Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Zen Technologies Limited
    Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Wexford Health Sources Inc:企業の戦略的SWOT分析
    Wexford Health Sources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Pharmascience Inc:企業のM&A・事業提携・投資動向
    Pharmascience Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pharmascience Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Himatsingka Seide Ltd:企業の戦略・SWOT・財務分析
    Himatsingka Seide Ltd - Strategy, SWOT and Corporate Finance Report Summary Himatsingka Seide Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Entergy Corporation (ETR):電力:M&Aディール及び事業提携情報
    Summary Entergy Corporation (Entergy) is an integrated energy company that generates, transmits, distributes and sells electricity. The company generates electricity from various sources including natural gas, nuclear, coal, hydroelectric, solar and oil based power plants. Entergy also operates natu …
  • CNOOC Ltd (883):石油・ガス:M&Aディール及び事業提携情報
    Summary CNOOC Ltd (CNOOC) is an upstream oil and gas company. It carries out exploration, development, production and sale of crude oil and natural gas. The company has operations in Bohai, Western South China Sea, Eastern South China Sea and East China Sea in offshore China. It operates either inde …
  • Inter Parfums SA:企業の戦略・SWOT・財務情報
    Inter Parfums SA - Strategy, SWOT and Corporate Finance Report Summary Inter Parfums SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆